Recent Quotes (30 days)

You have no recent quotes
chg | %

Takeda Pharmaceutical Co Ltd news

   Watch this stock
Showing stories 1 - 10 of about 121   

Articles published

4502 5,753.00 -11.00 (-0.19%)
price chart
Moody's confirms Takeda Pharmaceutical's A1 ratings; outlook negative
Takeda Pharmaceutical Company Limited is the largest pharmaceutical company in Japan in terms of revenue. It has well-established business franchises in Japan, the US and EU, and a presence in over 70 countries.
Japan's Takeda Pharmaceutical sees 16 percent profit rise on strong drug sales
TOKYO Japan's Takeda Pharmaceutical Co Ltd (4502.T) on Wednesday forecast operating profit to grow 16 percent in the current fiscal year on strong sales of drugs like cancer treatment Ninlaro and bowel disease drug Entyvio.
Takeda and PRA Health Sciences Announce Transformational Clinical Development ...
OSAKA, Japan & RALEIGH, N.C.--(BUSINESS WIRE)--PRA Health Sciences, Inc. (NASDAQ: PRAH) and Takeda Pharmaceutical Company Limited (TSE: 4502) announced today that the companies have entered into a new partnership agreement under ...
Raleigh's PRA Health signs 'transformational' deal with Takeda  Triangle Business Journal
Takeda earmarks $15bn for US pharmaceutical acquisitions
Takeda, Japan's largest pharmaceuticals group, is on the hunt for acquisitions in the US and has earmarked up to $15bn to spend on takeovers to boost its presence in the world's largest healthcare market, according to people briefed on the company's plans.
Teva Takeda Pharma shooting for $916m in sales in 2017
The Nagoya-based company was established in 2016 as a joint venture between Takeda Pharmaceutical and Israel's Teva Pharmaceutical Industries.
Takeda is buying Ariad Pharmaceuticals in a $5.2 billion deal
OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502) (“Takeda”) and Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) (“Ariad”) today announced that they have entered into a definitive agreement under which Takeda will ...
Takeda Pays 2012 Price For 2017 Model ARIAD  Seeking Alpha
Takeda Completes Acquisition of ARIAD Pharmaceuticals, Inc.
CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502) (“Takeda”) today announced the completion of its acquisition of ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) (“ARIAD”) for $24.00 per share in ...
BRIEF-Takeda Pharmaceutical completes acquisition of ARIAD Pharmaceuticals
BRIEF-Takeda Pharmaceutical completes acquisition of ARIAD Pharmaceuticals. Feb 17 Takeda Pharmaceutical Co Ltd : * Says co completes full acquisition of ARIAD Pharmaceuticals Inc on Feb. 16(U.
Valeant: Forget About Acquisition. Takeda Has Bought ARIAD
Takeda was planning an acquisition; however, instead of buying Valeant's Salix, the Japanese gastro-pharma bought ARIAD (NASDAQ:ARIA) - an oncological business with a strong pipeline and significant pricing power.
BRIEF-Takeda Pharmaceutical says PRA Health Sciences and Takeda Partnership ...
BRIEF-Takeda Pharmaceutical says PRA Health Sciences and Takeda Partnership Expands to Japan. Feb 15 Takeda Pharmaceutical Co Ltd : * Says PRA Health Sciences Inc and Takeda Pharmaceutical Company Limited have agreed to a new partnership ...